Aradigm
HomeAboutProductsTechnologiesInvestorsCareers
Press Releases

Investor Relations

Events & Presentations

Corporate Governance

Financial Information

Stock Information

Contact Us


All Releases
View Summary Aradigm Corporation Receives Nasdaq Notice of Non-Compliance
May 24, 2006
PDF 11.2 KB Add to Briefcase
View Summary Aradigm Provides Further Comments on Restructuring and Cash Used in Operations
May 17, 2006
PDF 12.1 KB Add to Briefcase
View Summary Aradigm Reports First Quarter 2006 Financial Results and Corporate Restructuring
May 15, 2006
PDF 17.8 KB Add to Briefcase
View Summary Aradigm Receives FDA Orphan Drug Designation of Liposomal Ciprofloxacin for Cystic Fibrosis
May 9, 2006
PDF 11.7 KB Add to Briefcase
View Summary Aradigm Announces Approval of Application to Transfer Stock Listing to Nasdaq Capital Markets
May 1, 2006
PDF 11.1 KB Add to Briefcase
View Summary Aradigm Announces Update by Novo Nordisk on AERx Inhaled Insulin Phase 3 Clinical Program
Apr 28, 2006
PDF 11.9 KB Add to Briefcase
View Summary Aradigm and Canadian Department of National Defence Extend AERx Liposomal Ciprofloxacin Development Program
Apr 26, 2006
PDF 11.9 KB Add to Briefcase
View Summary Aradigm Corporation First Quarter 2006 Earnings and Conference Call Notification
Apr 26, 2006
PDF 11.1 KB Add to Briefcase
View Summary Aradigm Corporation Applies to Transfer Listing to Nasdaq Capital Market
Apr 24, 2006
PDF 11.4 KB Add to Briefcase
View Summary Aradigm Corporation Receives Nasdaq Notice of Non-Compliance With Nasdaq Marketplace Rules
Mar 31, 2006
PDF 11.5 KB Add to Briefcase
View Summary Aradigm and APT Pharmaceuticals Initiate Phase 2 Clinical Program of Novel Treatment for Asthma
Mar 23, 2006
PDF 13.4 KB Add to Briefcase
View Summary Aradigm Reports Novo Nordisk to Initiate Additional Phase 3 Clinical Trials of AERx Diabetes Management System
Mar 7, 2006
PDF 11.9 KB Add to Briefcase
View Summary Aradigm Corporation to Present at the Cowen & Co. 26th Annual Health Care Conference
Feb 28, 2006
PDF 10.5 KB Add to Briefcase
View Summary Aradigm Announces Fourth Quarter and Year End 2005 Financial Results
Feb 22, 2006
PDF 16.9 KB Add to Briefcase
View Summary Aradigm Corporation Fourth Quarter and Full Year 2005 Earnings and Conference Call Notification
Feb 15, 2006
PDF 11.0 KB Add to Briefcase
View Summary Aradigm Files Request for Orphan Drug Designation for Inhaled Liposomal Ciprofloxacin for Cystic Fibrosis
Jan 6, 2006
PDF 13.1 KB Add to Briefcase
Showing 201-216 of 216 Page: 1 ... 9 10 11  Previous 20
= add release to Briefcase
CONTACT NEWS & EVENTS LEGAL SITE MAP ©2017 Aradigm Corporation. All Rights Reserved.